Monoclonal antibody (mAb) product innovation aim of facility expansion in KansasAugust 23, 2024A $130-million investment through 2026 is expected to bolster production and development of monoclonal antibody-based therapy, including a potential product in canine dermatology.
SPONSORED CONTENTThis new food helps puppies with digestive issuesHill's Prescription Diet i/d Kitten helps ease digestive upsets with food specialized for kittens, including our ActivBiome+ Digestion formula. + Learn More